What's breaking now, across thousands of outlets.
AstraZeneca’s leadership hinted at where the cost cuts and job losses from the company’s new restructuring program might fall on a call with journalists Friday. “We are losing patent protection for Farxiga ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Key PointsState Street SPDR S&P Bank ETF provides more diversified exposure with 107 holdings compared to 30 for iShares U.S. Regional Banks ETF.
Key PointsEven if there’s not one in the immediate offing, a recession will materialize sooner or later.
Andy Street, the former managing director of John Lewis and former Mayor of the West Midlands, is the latest to criticise the handling of rescue talks - as thousands of jobs hang in the balance.
Pakistani human rights lawyer Imaan Mazari and her husband Hadi Ali Chattha have been sentenced to 10 years in prison in a case involving the removal of road barriers during an England cricket team's…
The chipmaker is falling despite a competitor's bullish results.
Bambusa Therapeutics Inc. shares slipped 7% in its trading debut after the early-stage biotech focused on dermatology and autoimmune diseases raised $168.9 million in a US initial public offering.
